MV Mateos

2.5k citations

37 papers · 750 indexed · h-index 12

Impact in

Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 10%

Papers in ⓘ

Hematology 35
- Multiple Myeloma Research and Treatments 29
- Hematopoietic Stem Cell Transplantation 4
Oncology 20
- Cancer Treatment and Pharmacology 8
- Peptidase Inhibition and Analysis 5

Co-authors: Jesús F. San Miguel (26 shared papers)María‐Belén Vídriales (3 shared papers)Marcos González (4 shared papers)Josè Antonio Pérez-Simón (3 shared papers)Dolores Caballero (3 shared papers)Jesús María Hernández‐Rivas (2 shared papers)Lourdes Vázquez (2 shared papers)Mauricio Ocqueteau (1 shared paper)
Journals: HemaSphere (6 papers)Bone Marrow Transplantation (4 papers)Leukemia (4 papers)Annals of Oncology (4 papers)Haematologica (2 papers)
Partner nations: Spain United States Germany

In The Last Decade

MV Mateos

37 papers receiving 739 citations

Peers

Countries citing papers authored by MV Mateos

Since Specialization

Citations

This map shows the geographic impact of MV Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MV Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MV Mateos more than expected).

Fields of papers citing papers by MV Mateos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MV Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MV Mateos. The network helps show where MV Mateos may publish in the future.

Co-authors

The 25 scholars most cited alongside MV Mateos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with MV Mateos Line = papers co-authored together MV Mateos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. Journal of Clinical Oncology ·Juana Ciudad, Jesús F. San Miguel, M C López-Berges, María‐Belén Vídriales, Berta Valverde, Mauricio Ocqueteau, G. Ares Mateos, Marı́a Dolores Caballero, Jesús María Hernández‐Rivas, Manuel Moro, MV Mateos, (unknown)	1998	132
2	Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry Haematologica ·Roberto JP Magalhaes, María‐Belén Vídriales, Bruno Paiva, Carlos Fernández, Ramón García‐Sánz, MV Mateos, Norma C. Gutiérrez, Quentin Lécrevisse, Juan F. Blanco, Jesús María Hernández‐Rivas, Natalia de las Heras, Joaquín Martínez‐López, (unknown), Elaine Sobral da Costa, Enrique M. Ocio, Martín Pérez‐Andrés, Ângelo Maiolino, Márcio Nucci, Javier de la Rubia, Juan José Lahuerta, Jesús F. San Miguel, (unknown), (unknown)	2012	125
3	Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation Leukemia ·Josè Antonio Pérez-Simón, Dolores Caballero, María Díez‐Campelo, Ricardo López‐Pérez, G. Ares Mateos, Consuelo del Cañizo, Lourdes Vázquez, María‐Belén Vídriales, MV Mateos, Marcos González, Jesús F. San Miguel	2002	83
4	Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma Leukemia ·Meletios Α. Dimopoulos, Xavier Leleu, Antonio Palumbo, Philippe Moreau, Michel Delforge, Michèle Cavo, Heinz Ludwig, Gareth J. Morgan, Faith E. Davies, Pieter Sonneveld, Stephen Schey, Sonja Zweegman, Mona Hansson, Katja Weisel, MV Mateos, T. Facon, Jesús F. San Miguel	2014	80
5	Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning Bone Marrow Transplantation ·David Valcárcel, Rodrigo Martino, Dolores Caballero, MV Mateos, Josè Antonio Pérez-Simón, (unknown), Francesc Fernandez, Joan Bargay, Eduardo Muñiz‐Díaz, Marcos González, Jesús F. San Miguel, Jorge Sierra	2003	66
6	Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation Bone Marrow Transplantation ·Josè Antonio Pérez-Simón, Alejandro Martı́n, Dolores Caballero, M Corral, M J Nieto, Marcos González, Lourdes Vázquez, C López-Berges, MC Cañizo, MV Mateos, (unknown), Jesús F. San Miguel	1999	60
7	Defining and treating high-risk multiple myeloma Leukemia ·Saad Z. Usmani, Paula Rodríguez‐Otero, Manisha Bhutani, MV Mateos, Jesús F. San Miguel	2015	46
8	Bortezomib in multiple myeloma Best Practice & Research Clinical Haematology ·MV Mateos, Jesús F. San Miguel	2007	40
9	Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry Bone Marrow Transplantation ·M.C. del Cañizo, Carmen Martı́nez, E. Condé, Carlos Vallejo, Salut Brunet, Guillermo Sanz, MV Mateos	2003	17
10	Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes Leukemia ·Parameswaran Hari, MV Mateos, Rafat Abonour, Stefan Knop, Jack W. Singer, Heinz Ludwig, Kevin Song, Roman Hájek, Philippe Moreau, David S. Siegel, Shibao Feng, Mihaela Obreja, Sanjay Aggarwal, Karim Iskander, Hartmut Goldschmidt	2017	16
11	Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation Bone Marrow Transplantation ·Ricardo López‐Pérez, Ramón García‐Sánz, David González, Ana Balanzategui, Carmen Chillón, I Alaejos, MV Mateos, MD Caballero, M Corral, Alberto Órfão, Marcos González, Jesús F. San Miguel	2001	14
12	Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide? Haematologica ·Sergio Matarraz, Bruno Paiva, María Díez‐Campelo, (unknown), (unknown), MV Mateos, Pilar Giraldo, Miguel‐Teodoro Hernández, Jesús F. San Miguel, Alberto Orfao, (unknown)	2012	12
13	Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm) Antonio Palumbo, Rudolf Schlag, Nuriet K. Khuageva, Ofer Shpilberg, Meletios Α. Dimopoulos, Martin Kropff, Ivan Špıčka, MT Petrucci, Michel Delforge, MV Mateos, Dixie‐Lee Esseltine, K Liu, William Deraedt, H. Van de Velde, Paul G. Richardson, JF San-Miguel	2008	7
14	Split dosing of daratumumab (D) in a phase 1b study of D plus carfilzomib (K)-based regimens in patients (pts) with multiple myeloma (MM) Annals of Oncology ·Saad Z. Usmani, Andrzej Jakubowiak, Ajai Chari, Sagar Lonial, MV Mateos, Lotfi Benboubker, Kang Wu, Nushmia Z. Khokhar, J. Wang, Parul Doshi, Philippe Moreau	2017	6
15	Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation PubMed ·Jesús F. San Miguel, MV Mateos	2013	5
16	DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE (DVD) VS BORTEZOMIB AND DEXAMETHASONE (VD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (CASTOR) Hematological Oncology ·Suzanne Lentzsch, Katja Weisel, MV Mateos, Vânia Hungria, Markus Munder, Ajay K. Nooka, Tomer M. Mark, Hang Quach, Emma C. Scott, Jeong Hyun Lee, Pieter Sonneveld, Tineke Casneuf, Christopher Chiu, Xiang Qin, Hebat Allah A. Amin, Piruntha Thiyagarajah, Jordan M. Schecter, Ming Qi, Andrew Spencer	2017	5
17	A172 Peripheral Neuropathy with VMP Resolves in the Majority of Patients and Shows a Rate Plateau Clinical Lymphoma & Myeloma ·MV Mateos, PG Richardson, Rudolf Schlag, N Khuageva, Meletios Α. Dimopoulos, Ofer Shpilberg, Martin Kropff, (unknown), Antonio Palumbo, Rik Schots, K Liu, Andrew Cakana, Helgi van de Velde, Jesús F. San Miguel	2009	5
18	Risk Stratification in the Era of Novel Therapies The Cancer Journal ·Jesús F. San Miguel, MV Mateos, Norma C. Gutiérrez	2009	4
19	P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL HemaSphere ·Pieter Sonneveld, A.A. Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, (unknown), Vânia Hungria, Markus Munder, MV Mateos, TM Mark, M-D Levin, T. Ahmadi, Xiang Qin, Wendy Garvin Mayo, X Gai, Jodi Carey, Robin Carson, Andrew Spencer	2022	3
20	Pembrolizumab in combination with pomalidomide and low-dose dexamethasone in refractory or relapsed and refractory multiple myeloma (rrMM): Randomized, phase 3 KEYNOTE-183 study Annals of Oncology ·Enrique M. Ocio, Jatin J. Shah, Sundar Jagannath, MV Mateos, Antonio Palumbo, Uma Kher, Patricia Marinello, Jesús F. San Miguel	2016	2

About MV Mateos

MV Mateos is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 37 papers that have together received 750 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Protein Degradation and Inhibitors (11 papers), Cancer Treatment and Pharmacology (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Peptidase Inhibition and Analysis (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (650 citations), Transplantation (32 citations), Oncology (263 citations), Genetics (97 citations) and Immunology (158 citations). MV Mateos has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Jesús F. San Miguel, María‐Belén Vídriales, Marcos González, Josè Antonio Pérez-Simón, Dolores Caballero, Jesús María Hernández‐Rivas, Lourdes Vázquez, Mauricio Ocqueteau, Juana Ciudad and Berta Valverde. Their work appears in journals such as HemaSphere, Bone Marrow Transplantation, Leukemia, Annals of Oncology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact